Summit Therapeutics Inc. revenue

Summit Therapeutics Inc.'s revenue was $0 in fiscal 2024.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Summit Therapeutics Inc.: revenue history, annual
Fiscal year	2016Jan 2016	2017Jan 2017	2018Jan 2018	2019Jan 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024
Revenue	0	3	33	57	1	2	1	0	0
Growth on the year before	—	—	+970.8%	+72.7%	−98.5%	+110.3%	−61.0%	−100.0%	—
Gross profit	−31	−33	−34	—	—	—	—	—	—

US$ thousands unless shown otherwise. Fiscal quarters.

Summit Therapeutics Inc.: revenue history, quarterly
Quarter	2022 Q3Sept 2022	2022 Q4Dec 2022	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023	2024 Q3Sept 2024	2024 Q4Dec 2024
Revenue	220	0	0	0	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	−100.0%	—	—	—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Summit Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Summit Therapeutics Inc.